- In July 2023, Infant Bacterial Therapeutics received orphan drug designation from the US FDA for its bacterial product IBP-1016, aimed at treating infants with gastroschisis. This designation supports the development of treatments for rare conditions
- In December 2023, MaaT Pharma announced the clinical trial results for MaaT013, a treatment for acute graft-versus-host disease (aGvHD). The drug showed a well-tolerated safety profile and an 81% survival rate, highlighting its potential effectiveness
- In July 2023, MaaT Pharma joined the Microbiome Therapeutics Innovation Group, an organization focused on advancing the research and development of FDA-approved microbiome therapies for clinical use, further strengthening its role in the microbiome therapy landscape
- In April 2023, Finch Therapeutics entered a clinical trial agreement with Brigham and Women’s Hospital to evaluate CP101, a novel microbiome-based therapy for the treatment of ulcerative colitis, aiming to advance therapeutic options for the condition
Frequently Asked Questions
The market is segmented based on Segmentation, By Product (Probiotics, Prebiotics, Medical Foods, Supplements, and Others), Application (Therapeutics, and Diagnostics), Disease Type (Obesity, Diabetes, Autoimmune Disorder, Metabolic and Gastrointestinal Disorders, Cancer, and Other Diseases) – Industry Trends and Forecast to 2031
.
The Global Human Microbiome Market size was valued at USD 905.49 USD Million in 2023.
The Global Human Microbiome Market is projected to grow at a CAGR of 22.95% during the forecast period of 2024 to 2031.
The major players operating in the market include ENTEROME, Yakult, DuPont, Metabiomics Corporation, ViThera Pharmaceuticals , Second Genome , MICROBIOME THERAPEUTICS LLC, Vedanta Biosciences , Osel , Merck Sharp & Dohme Corp, Seres Therapeutics, Synthetic Biologics , Synlogic, 4D pharma plc, Metabogen AB, Ritter Pharmaceuticals, Symberix, Symbiotix Biotherapies -.
The market report covers data from the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E., South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America..
